These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8937845)

  • 41. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
    Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
    Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
    Esposito S; Noviello S; Ianniello F
    Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
    Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
    Dias R; Louro D; Caniça M
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2098-105. PubMed ID: 16723571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
    Wierzbowski AK; Boyd D; Mulvey M; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4635-40. PubMed ID: 16251306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.
    Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan.
    Hsueh PR; Teng LJ; Lee LN; Yang PC; Ho SW; Lue HC; Luh KT
    Microb Drug Resist; 2002; 8(1):27-33. PubMed ID: 12002646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
    Johnson DM; Stilwell MG; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):69-74. PubMed ID: 16546341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [In vitro antibacterial activity of pristinamycin against penicillin resistant Streptococcus pneumoniae].
    Fremaux A; Sissia G; Geslin P
    Pathol Biol (Paris); 1993 Sep; 41(7):636-40. PubMed ID: 8255615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa.
    Widdowson CA; Klugman KP
    Emerg Infect Dis; 1998; 4(2):277-81. PubMed ID: 9621199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates.
    Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1996 Feb; 24(2):113-6. PubMed ID: 9147907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
    Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
    Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High prevalence of multidrug-resistant international clones among macrolide-resistant Streptococcus pneumoniae isolates in immunocompromised patients in Tunisia.
    Raddaoui A; Tanfous FB; Chebbi Y; Achour W; Baaboura R; Benhassen A
    Int J Antimicrob Agents; 2018 Dec; 52(6):893-897. PubMed ID: 29698665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance.
    Thomson KS; Chartrand SA; Sanders CC; Block SL
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():15-9. PubMed ID: 10404332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic detection of constitutive and inducible clindamycin resistance in clinical isolates of Staphylococcus aureus and coagulase negative Staphylococcus on routine susceptibility plate.
    Fomda BA; Peer MA; Zahoor D; Thokar MA; Nasir RA
    J Commun Dis; 2010 Mar; 42(1):19-26. PubMed ID: 22468547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of the efflux-mediated erythromycin resistance transposon in Streptococcus pneumoniae.
    Azadegan A; Ahmadi A; Lari AR; Talebi M
    Ann Lab Med; 2015 Jan; 35(1):57-61. PubMed ID: 25553281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods.
    Fasola EL; Bajaksouzian S; Appelbaum PC; Jacobs MR
    Antimicrob Agents Chemother; 1997 Jan; 41(1):129-34. PubMed ID: 8980768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.
    Oster P; Zanchi A; Cresti S; Lattanzi M; Montagnani F; Cellesi C; Rossolini GM
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2510-2. PubMed ID: 10508033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina.
    Denamiel G; Llorente P; Carabella M; Rebuelto M; Gentilini E
    J Vet Med B Infect Dis Vet Public Health; 2005 Apr; 52(3):125-8. PubMed ID: 15876224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.